Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Urol. 2015 Mar 7;194(2):316–322. doi: 10.1016/j.juro.2015.02.2943

Table 6.

Oncological outcomes and risk factors for cancer specific death after resection of RPR after radical nephrectomy in the literature.

References No. Patients Time of Study RPR Location Follow-up (months) No. Patients who had RPR surgery (%) Recurrence/Progression (%) Death from Cancer (%) NED (%) 1, 3, 5 Year CSS (%) Risk Factors for cancer-specific death
Current study 102 1990-2014 RPR 32 102 (100) 60 (58.8) 33 (32.4) 40 (39.2) 92, 71, 52 N-stage, recurrent tumor size
*Russell et al.27 22 1993-2012 LN 22.3 22 (100) 10 (45%) 2 (9) 12 (54.5) NA NA
*Paparel et al.26 72 Not specified RPR 26.4 46 (66) NA 28 (38) 12 (17) 74, 55, 46 Time to recurrence, surgical resection of RPR
Margulis et al.9 54 1990-2007 RPR 41 54 (100) 35 (65) 23 (43) 11 (20) NA Positive surgical margin at RPR resection, recurrent tumor size, LDH
Master et al.17 14 1990-2003 Soft tissue 34 14 (100) 9 (64) 9 (64) NA 86, 40, 30 NA
Schrodter et al.10 13 1991-2000 Soft tissue 36.9 13 (100) 8 (61) 7 (54) 5 (38) NA ,56, NA Time to recurrence, recurrent tumor size
Itano et al.7 30 1970-1998 Soft tissue 39 10 (33) 8 (80) 25 (83) 2 (20) 66, 40, 28 Surgical resection of RPR
Sandhu et al.6 16 1994-2004 RPR 12 14 (87) 11 (68) 5 (36) 5 (31) NA NA
Bruno et al.28 34 1989-2004 RPR 16.9 16 (47) NA 26 (76) 3 (9) 63, 31,18 Surgical resection of RPR
Boorjian et al.29 15 1970-2004 Soft tissue, LN 18 15 (100) 10 (67) 6 (40) 5 (33) **65, 35 NA
Tanguay et al.30 16 1983-1994 Soft tissue 23.5 16 (100) 10 (62) 4 (25) 6 (38) NA NA
Esrig et al.8 11 1973-1990 Soft tissue NA 10 (91) 7 (63) 4 (36) 4 (36) 55, 36, NA NA
*

Multi-institutional study

**

CSS (%) at 2 and 4 years respectively

Multivariate Cox regression analysis (vs Univariate Cox regression analysis)

Retroperitoneal recurrence (RPR) defined as soft tissue, ipsilateral adrenal gland, ipsilateral lymph nodes (LN)

NA, not applicable

NED, no evidence of disease